CHAM Bill Elliot;CHAM Kai Elliot;CHASE Tania Robyn
发明人:
CHAM Bill Elliot,CHASE Tania Robyn,CHAM Kai Elliot
申请号：
IL26150418
公开号：
IL261504D0
申请日:
2018.09.02
申请国别(地区):
IL
年份:
2018
代理人:
摘要：
The present invention relates to the use of glycoalkaloids, such as solasonine and solamargine, in treatment of cancer such as skin cancer, and to compositions for use in such treatment. More particularly the present invention relates to providing an improved, substantially stable formulation for the glycoalkaloids which minimises or reduces degradation of these active molecules.
